Lexaria Bioscience Corp. (LEXX)
Market Open
12 Jun, 17:50
NASDAQ (CM) NASDAQ (CM) Primary $
0. 61
-0.03
-4.4625%
$
13M Market Cap
- P/E Ratio
- Div Yield
81,303 Volume
0 Eps
$ 0.64
Previous Close 
Want to track LEXX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexaria Bioscience Corp. (LEXX) Statistics
Valuation metrics
Market Cap 13M
Enterprise value 7.99M
Trailing P/E (ttm) -1.63
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 35.39
Price/Book (mrq) 2.36
Enterprise Value/Revenue 21.71
Enterprise Value/EBITDA -0.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 54.38K
Average volume (90 days) 180.33K
Price summary
52-Week low 0.46
52-Week high 1.55
Beta -
50-Day moving average 0.73
200-Day moving average 0.79
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 12 Jan 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -25.9%
Operating margin -25.72%
Operational effectiveness
Return on assets -1.47%
Return on equity -1.9%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 26.88%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
